These novel medications , Tirzepatide , represent a remarkable advancement in addressing obesity and potentially associated ailments . They all are classified as GLP-1 hormone agonists , signifying they to mimic the endogenous GLP-1 substance , stimulating metabolic production and lowering food intake. Despite Retatrutide every functions largely si